News

Under the collaboration deal, NCI and NHGRI will apply Horizon’s rAAV gene editing technology (GENESIS) to engineer human isogenic disease models for its researchers. In addition, X-MAN (gene

The product, whose manufacturing and packaging has been completed, will be made available through Marisol Therapeutics for patient usage. The second Cannabis Science Brand extract-based formulation contains the

Perifosine is an oral anticancer treatment that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway. The drug is in two Phase 3 programs for the treatment of

Alogliptin is a selective dipeptidyl peptidase IV inhibitor (DPP-4i) which is being evaluated in the US to treat type 2 diabetes as an adjunct to diet and exercise.

By adopting IBM Initiate, DB2, Cognos, and WebSphere software into its MEDxConnect platform, Compressus intends to look into the issue of interoperability. MEDxConnect provides an easy way to

Intermezzo is available in doses of 1.75 mg and 3.5 mg as a sublingual tablet that contains a bicarbonate-carbonate buffer. The approval is backed by two placebo-controlled studies

According to the company, the BD MAX MRSA Assay is designed to be used on BD MAX automated molecular system to rapidly identify methicillin-resistant Staphylococcus aureus (MRSA) in

VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy in patients with type 1 Gaucher disease. The company hopes to increase the production capacity

Arcalyst is used to treat Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). The sBLA submission for Arcalyst is backed by positive